These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22393957)

  • 21. Effect of neohesperidin dihydrochalcone on the activity and stability of alpha-amylase: a comparative study on bacterial, fungal, and mammalian enzymes.
    Kashani-Amin E; Ebrahim-Habibi A; Larijani B; Moosavi-Movahedi AA
    J Mol Recognit; 2015 Oct; 28(10):605-13. PubMed ID: 25808616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
    Jordan VC; O'Malley BW
    J Clin Oncol; 2007 Dec; 25(36):5815-24. PubMed ID: 17893378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts.
    Lai A; Kahraman M; Govek S; Nagasawa J; Bonnefous C; Julien J; Douglas K; Sensintaffar J; Lu N; Lee KJ; Aparicio A; Kaufman J; Qian J; Shao G; Prudente R; Moon MJ; Joseph JD; Darimont B; Brigham D; Grillot K; Heyman R; Rix PJ; Hager JH; Smith ND
    J Med Chem; 2015 Jun; 58(12):4888-904. PubMed ID: 25879485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Capitalizing on the complexities of estrogen receptor pharmacology in the quest for the perfect SERM.
    McDonnell DP; Chang CY; Norris JD
    Ann N Y Acad Sci; 2001 Dec; 949():16-35. PubMed ID: 11795348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
    Dutertre M; Smith CL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):431-7. PubMed ID: 11046073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis for an unexpected mode of SERM-mediated ER antagonism.
    Wu YL; Yang X; Ren Z; McDonnell DP; Norris JD; Willson TM; Greene GL
    Mol Cell; 2005 May; 18(4):413-24. PubMed ID: 15893725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.
    Crabtree JS; Peano BJ; Zhang X; Komm BS; Winneker RC; Harris HA
    Mol Cell Endocrinol; 2008 Jun; 287(1-2):40-6. PubMed ID: 18367319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and biological evaluation of novel indole-xanthendione hybrids as selective estrogen receptor modulators.
    Singla R; Gupta KB; Upadhyay S; Dhiman M; Jaitak V
    Bioorg Med Chem; 2018 Jan; 26(1):266-277. PubMed ID: 29198894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens.
    Chang KC; Wang Y; Bodine PV; Nagpal S; Komm BS
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):117-24. PubMed ID: 19914376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of Triphenylethylene Bisphenols as Aromatase Inhibitors That Also Modulate Estrogen Receptors.
    Lv W; Liu J; Skaar TC; O'Neill E; Yu G; Flockhart DA; Cushman M
    J Med Chem; 2016 Jan; 59(1):157-70. PubMed ID: 26704594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flexible estrogen receptor modulators: synthesis, biochemistry and molecular modeling studies for 3-benzyl-4,6-diarylhex-3-ene and 3,4,6-triarylhex-3-ene derivatives.
    Smith HM; Knox AJ; Zisterer DM; Lloyd DG; Meegan MJ
    Med Chem; 2007 Mar; 3(2):135-55. PubMed ID: 17348852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction and analysis of ligands against estrogen related receptor alpha.
    Chitrala KN; Yeguvapalli S
    Asian Pac J Cancer Prev; 2013; 14(4):2371-5. PubMed ID: 23725143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro and In Silico Analyses of the Inhibition of Human Aldehyde Oxidase by Bazedoxifene, Lasofoxifene, and Structural Analogues.
    Chen S; Austin-Muttitt K; Zhang LH; Mullins JGL; Lau AJ
    J Pharmacol Exp Ther; 2019 Oct; 371(1):75-86. PubMed ID: 31289113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7.
    Diel P; Olff S; Schmidt S; Michna H
    Planta Med; 2001 Aug; 67(6):510-4. PubMed ID: 11509969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The binding site for neohesperidin dihydrochalcone at the human sweet taste receptor.
    Winnig M; Bufe B; Kratochwil NA; Slack JP; Meyerhof W
    BMC Struct Biol; 2007 Oct; 7():66. PubMed ID: 17935609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions.
    Lonard DM; Smith CL
    Steroids; 2002 Jan; 67(1):15-24. PubMed ID: 11728517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of 10-dehydrooxyglycyuralin E as a selective human estrogen receptor alpha partial agonist.
    Saito N; Kawase K; Yamashita N; Tang Y; Wang Y; Wang J; Liu Y; Li N; Li W; Cheng MS; Koike K; Kanno Y; Nemoto K
    Bioorg Chem; 2019 Jul; 88():102977. PubMed ID: 31100617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment.
    Sirianni R; Zolea F; Chimento A; Ruggiero C; Cerquetti L; Fallo F; Pilon C; Arnaldi G; Carpinelli G; Stigliano A; Pezzi V
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2238-50. PubMed ID: 23074235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
    Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY
    J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening.
    Shen J; Tan C; Zhang Y; Li X; Li W; Huang J; Shen X; Tang Y
    J Med Chem; 2010 Jul; 53(14):5361-5. PubMed ID: 20553023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.